pioglitazone has been researched along with Acute Myelogenous Leukemia in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Esmaeili, S | 1 |
| Salari, S | 1 |
| Kaveh, V | 1 |
| Ghaffari, SH | 1 |
| Bashash, D | 1 |
| Li, Y | 1 |
| Tang, T | 1 |
| Xiao, J | 1 |
| Li, B | 1 |
| Yang, W | 1 |
| Xie, S | 1 |
| Du, Y | 1 |
| Huang, K | 1 |
| Nie, D | 1 |
| Thomas, S | 1 |
| Schelker, R | 1 |
| Klobuch, S | 1 |
| Zaiss, S | 1 |
| Troppmann, M | 1 |
| Rehli, M | 1 |
| Haferlach, T | 1 |
| Herr, W | 1 |
| Reichle, A | 1 |
1 review available for pioglitazone and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Comparative efficacy and safety of eleven induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia: a network meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Induction Chemotherapy; Leukemia, Myeloid, A | 2022 |
2 other studies available for pioglitazone and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Alteration of PPAR-GAMMA (PPARG; PPARĪ³) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARĪ³ stimulation using pioglitazone on AML cells.
Topics: Carrier Proteins; Gene Expression; Humans; Leukemia, Myeloid, Acute; Pioglitazone; PPAR gamma; PTEN | 2021 |
Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Drug Resistance, Neoplasm | 2015 |